Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £20.17m
IHC Live PriceLast checked at - London Stock Exchange

Intraday Inspiration Hlt Share Chart

Directorate Change

28 Jan 2025 07:00

RNS Number : 8562U
Inspiration Healthcare Group PLC
28 January 2025
Β 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Β 

Board changes

Β 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces the retirement of Bob Beveridge, Non-Executive Director ("NED") who is stepping down after nine years in line with best practice. Bob will be replaced as NED and Chair of the Audit Committee by Richard Jones. The Board wish to thank Bob for his years of service and commitment to Inspiration Healthcare during his tenure and are delighted to be able to appoint Richard to the role. Both changes will come into effect from 31 January 2025.

Β 

Richard is a seasoned healthcare and life sciences professional with extensive experience as a board member of publicly listed companies. He has spent more than 20 years serving in both independent NED and Executive Director roles and has acted as a key adviser across a diverse range of public and private companies in the life sciences space. He has expertise across a wide spectrum of Board issues and has worked extensively outside the UK PLC market having completed a US reverse merger as CFO for a UK biotech company in 2019.

Β 

Currently he is a Senior Independent Director and Audit Committee Chair of Alliance Pharma PLC, an AIM listed international consumer healthcare company where he is closely involved in all aspects of the business. Formerly, he was Chief Financial Officer ("CFO") and Company Secretary of the UK and Ireland's leading supplier of tele-radiology services, Medica Group Ltd. His CFO and Board experience also includes Mereo Biopharma PLC and Shield Therapeutics PLC.

Β 

Roy Davis, Executive Chairman of Inspiration Healthcare said: "We are delighted to welcome Richard on board, and we are excited to be able to tap into his extensive capital markets experience, as well as his in-depth knowledge of the US market where we continue to grow our presence.

Β 

"On behalf of the Board, I would like to thank Bob for his dedication and commitment to Inspiration Healthcare over almost a decade. We will be sad to see him go, and we wish him all the very best for his future plans."

Β 

Bob Beveridge, outgoing Non-Executive Director said: "I have thoroughly enjoyed my time with the Inspiration Healthcare team over the years. I believe they are at a key transitional phase, and I know they will be a great success. I wish them well for a bright future."

Β 

Richard Jones, incoming Non-Executive Director added: "I am looking forward to joining the Board of Inspiration Healthcare and sharing my PLC and life sciences industry expertise with the team."

Β 

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Richard Crispin Morgan Jones (aged 58 years) holds / has held the following directorships/partnerships in the last five years:

Β 

Current directorships / partnerships

Previous directorships / partnerships in last 5 years

Alliance Pharma plc

Global Diagnostics Ireland Ltd

C4X Discovery Holdings Limited

Global Retinopathy Screening Ltd

Hampshire Topco Limited

JCA Seminars Limited

Hero Acquisitions Limited

Medica Australia Pty Ltd

HSS Hire Group plc

Medica Group Limited

HSS Hire Service Finance Limited

Medica IT Services Limited

RCMJ Consultancy Ltd

Medica Reporting Finance Limited

Medica Reporting Limited

Medica Reporting Services Limited

Medica US Inc

Med-IDX Pty Ltd

Med-IDX UK Limited

Mereo Biopharma 1 Limited

Mereo Biopharma 2 Limited

Mereo Biopharma 3 Limited

Mereo Biopharma 4 Limited

Mereo Biopharma Group plc

Mereo BioPharma Ireland Limited

Mereo MereoCo Inc

Mereo US Holdings Inc

Moonlight Bidco Limited

Moonlight Midco 1 Limited

Moonlight Midco 2 Limited

Moonlight Topco Limited

Β 

Richard Crispin Morgan Jones does not hold any ordinary shares in the capital of the Company. There are no further disclosures to be made in accordance with AIM Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

Β 

For further information, please contact:

Β 

Inspiration Healthcare Group plc

Tel: +44 (0)330 175 0000

Roy Davis, Executive Chair

Alan Olby, Chief Financial Officer

Panmure Liberum (Nominated Adviser & Broker)

Tel: +44 (0)20 3100 2000

Richard Lindley

Will King

Β 

Walbrook PR Ltd (Media and Investor Relations)

Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com

Anna Dunphy

Mob: +44 (0) 7876 741 001

Louis Ashe-Jepson

Mob: +44 (0) 7747 515 393

Β 

About Inspiration Healthcare

Β 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

Β 

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOABRGDBLUDDGUR
Date   Source Headline
16th Jun 20267:00 amRNSFinal Results
2nd Jun 20267:01 amRNSNotice of Results
2nd Jun 20267:00 amRNSTransfer of Non-Core Products to Focus on Neonatal
14th Apr 20267:00 amRNSChange of Adviser
16th Mar 20269:33 amRNSHolding(s) in Company
16th Mar 20269:33 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSUK neonatal division wins NHS framework agreement
26th Feb 20269:23 amRNSHolding(s) in Company
12th Feb 20267:00 amRNSFull year trading update
10th Feb 20269:05 amRNSHolding(s) in Company
3rd Feb 20267:00 amRNSAppointment of Joint Broker
2nd Feb 202611:01 amRNSHolding(s) in Company
28th Jan 20261:40 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNSPurchasing agreement in the US
27th Jan 20269:46 amRNSHolding(s) in Company
26th Jan 202610:02 amRNSHolding(s) in Company
22nd Jan 20261:37 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSChange of auditor
16th Oct 20251:51 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSHalf-year Report
23rd Sep 20257:00 amRNSResults presentations for analysts and investors
19th Sep 20257:00 amRNSDirectorate Change
20th Aug 20257:00 amRNSTrading update and notice of results
24th Jul 20251:37 pmRNSResult of AGM
24th Jul 20257:00 amRNSAGM Statement
13th Jun 20259:16 amRNSPublication of AR, accounts & notice of AGM
6th Jun 20257:00 amRNSBoard Change
28th May 20257:00 amRNSUnaudited Preliminary results
23rd May 20257:00 amRNSNotice of Results
15th May 20255:01 pmRNSHolding(s) in Company
15th May 202510:06 amRNSHolding(s) in Company
1st Apr 202511:36 amRNSHolding(s) in Company
21st Mar 20252:49 pmRNSGrant of Options
12th Mar 20256:01 pmRNSHolding(s) in Company
12th Mar 20256:00 pmRNSDirector/PDMR Shareholding
24th Feb 20254:16 pmRNSDirector/PDMR Shareholding
21st Feb 20252:52 pmRNSDirector/PDMR Shareholding
18th Feb 20257:00 amRNSTrading update
10th Feb 20259:54 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirectorate Change
14th Jan 20254:08 pmRNSHolding(s) in Company
12th Dec 20247:00 amRNSAppointment of Chief Executive Officer
14th Nov 20247:00 amRNSBoard Change
4th Nov 20247:00 amRNSGrant of Covenant Waiver and Covenant Reset
2nd Oct 20247:00 amRNSHalf-year Report
17th Sep 202412:26 pmRNSResult of AGM
3rd Sep 20247:00 amRNSTrading update for the six months to 31 July 2024
5th Aug 20243:41 pmRNSHolding(s) in Company
2nd Aug 20247:00 amRNSNominated adviser and broker
31st Jul 20243:29 pmRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.